Overview Reviews Product Description Cancer-Targeting Compound 1 Product Videos Custom Field Size 20mg Alternative Names N/A CAS N° 1007581-62-5 Molecular weight 299.35 Formula C15H13N3O2S Solubility 10 mM in DMSO Target Others Note This product is available in other size, please contact us for more information Product Reviews Write a Review Write a Review × Cancer-Targeting Compound 1 Rating * Select Rating 1 star (worst) 2 stars 3 stars (average) 4 stars 5 stars (best) Name Review Subject * Comments *
Quick view Details Arrhythmic-Targeting Compound 1 MSRP: Now: £7,540 Add to Cart Quick view Details Arrhythmias-Targeting Compound 1 MSRP: Now: £6,546 Add to Cart Quick view Details Neuromuscular-targeting compound 1 MSRP: Now: £3,268 Add to Cart Quick view Details Itch-Targeting Compound 1 MSRP: Now: £7,484 Add to Cart Quick view Details Urinary Incontinence-Targeting Compound 1 MSRP: Now: £8,254 Add to Cart Quick view Details Neuromuscular Disorder-Targeting Compound 1 MSRP: Now: £28,722 Add to Cart Quick view Details Neurodegenerative Disorder-Targeting Compound 1 MSRP: Now: £3,626 Add to Cart Quick view Details Anti-MAGE-1 (Target for Cancer Immunotherapy) Monoclonal Antibody MSRP: Now: £794 Add to Cart Quick view Details MAGE-1 (Target for Cancer Immunotherapy) ; Clone SPM282 (Concentrate) | RA0576-C.1 MSRP: Was: Now: £340 - £1,268 Choose Options ×
Quick view Details Arrhythmias-Targeting Compound 1 MSRP: Now: £6,546 Add to Cart Quick view Details Neuromuscular-targeting compound 1 MSRP: Now: £3,268 Add to Cart Quick view Details Itch-Targeting Compound 1 MSRP: Now: £7,484 Add to Cart Quick view Details Urinary Incontinence-Targeting Compound 1 MSRP: Now: £8,254 Add to Cart Quick view Details Neuromuscular Disorder-Targeting Compound 1 MSRP: Now: £28,722 Add to Cart Quick view Details Neurodegenerative Disorder-Targeting Compound 1 MSRP: Now: £3,626 Add to Cart Quick view Details Anti-MAGE-1 (Target for Cancer Immunotherapy) Monoclonal Antibody MSRP: Now: £794 Add to Cart Quick view Details MAGE-1 (Target for Cancer Immunotherapy) ; Clone SPM282 (Concentrate) | RA0576-C.1 MSRP: Was: Now: £340 - £1,268 Choose Options ×
Quick view Details Neuromuscular-targeting compound 1 MSRP: Now: £3,268 Add to Cart Quick view Details Itch-Targeting Compound 1 MSRP: Now: £7,484 Add to Cart Quick view Details Urinary Incontinence-Targeting Compound 1 MSRP: Now: £8,254 Add to Cart Quick view Details Neuromuscular Disorder-Targeting Compound 1 MSRP: Now: £28,722 Add to Cart Quick view Details Neurodegenerative Disorder-Targeting Compound 1 MSRP: Now: £3,626 Add to Cart Quick view Details Anti-MAGE-1 (Target for Cancer Immunotherapy) Monoclonal Antibody MSRP: Now: £794 Add to Cart Quick view Details MAGE-1 (Target for Cancer Immunotherapy) ; Clone SPM282 (Concentrate) | RA0576-C.1 MSRP: Was: Now: £340 - £1,268 Choose Options ×
Quick view Details Itch-Targeting Compound 1 MSRP: Now: £7,484 Add to Cart Quick view Details Urinary Incontinence-Targeting Compound 1 MSRP: Now: £8,254 Add to Cart Quick view Details Neuromuscular Disorder-Targeting Compound 1 MSRP: Now: £28,722 Add to Cart Quick view Details Neurodegenerative Disorder-Targeting Compound 1 MSRP: Now: £3,626 Add to Cart Quick view Details Anti-MAGE-1 (Target for Cancer Immunotherapy) Monoclonal Antibody MSRP: Now: £794 Add to Cart Quick view Details MAGE-1 (Target for Cancer Immunotherapy) ; Clone SPM282 (Concentrate) | RA0576-C.1 MSRP: Was: Now: £340 - £1,268 Choose Options ×
Quick view Details Urinary Incontinence-Targeting Compound 1 MSRP: Now: £8,254 Add to Cart Quick view Details Neuromuscular Disorder-Targeting Compound 1 MSRP: Now: £28,722 Add to Cart Quick view Details Neurodegenerative Disorder-Targeting Compound 1 MSRP: Now: £3,626 Add to Cart Quick view Details Anti-MAGE-1 (Target for Cancer Immunotherapy) Monoclonal Antibody MSRP: Now: £794 Add to Cart Quick view Details MAGE-1 (Target for Cancer Immunotherapy) ; Clone SPM282 (Concentrate) | RA0576-C.1 MSRP: Was: Now: £340 - £1,268 Choose Options ×
Quick view Details Neuromuscular Disorder-Targeting Compound 1 MSRP: Now: £28,722 Add to Cart Quick view Details Neurodegenerative Disorder-Targeting Compound 1 MSRP: Now: £3,626 Add to Cart Quick view Details Anti-MAGE-1 (Target for Cancer Immunotherapy) Monoclonal Antibody MSRP: Now: £794 Add to Cart Quick view Details MAGE-1 (Target for Cancer Immunotherapy) ; Clone SPM282 (Concentrate) | RA0576-C.1 MSRP: Was: Now: £340 - £1,268 Choose Options ×
Quick view Details Neurodegenerative Disorder-Targeting Compound 1 MSRP: Now: £3,626 Add to Cart Quick view Details Anti-MAGE-1 (Target for Cancer Immunotherapy) Monoclonal Antibody MSRP: Now: £794 Add to Cart Quick view Details MAGE-1 (Target for Cancer Immunotherapy) ; Clone SPM282 (Concentrate) | RA0576-C.1 MSRP: Was: Now: £340 - £1,268 Choose Options ×
Quick view Details Anti-MAGE-1 (Target for Cancer Immunotherapy) Monoclonal Antibody MSRP: Now: £794 Add to Cart Quick view Details MAGE-1 (Target for Cancer Immunotherapy) ; Clone SPM282 (Concentrate) | RA0576-C.1 MSRP: Was: Now: £340 - £1,268 Choose Options
Quick view Details MAGE-1 (Target for Cancer Immunotherapy) ; Clone SPM282 (Concentrate) | RA0576-C.1 MSRP: Was: Now: £340 - £1,268 Choose Options